This cannabis ETF outperformed the S&P in 2025: Outlook for 2026

Yahoo Finance Published Updated Stocks
Sign in to save

Affected assets and topics

PORTFOLIO S&P SHARES MARKET

Why it matters

The AdvisorShares' Pure US Cannabis ETF (MSOS) outperformed the S&P 500 in 2025, driven by President Trump's executive order rescheduling marijuana, indicating a positive outlook for the cannabis industry.

Expected market reaction

Bullish Confidence 90% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on bullish sentiment with 90% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim This cannabis ETF outperformed the S&P in 2025: Outlook for 2026
AI inference Bullish · 90%
Generated 2026-01-13 23:00

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
32246

Original source

AdvisorShares' Pure US Cannabis exchange-traded fund (ETF) (MSOS) outperformed the S&P 500 (^GSPC) in 2025. President Trump's executive order rescheduling marijuana has sent the ETF surging. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure US Cannabis ETF, joins Asking for a Trend to explain where the cannabis industry stands right now. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend.

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on January 14, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

Llama 3.1 8B Instant (Groq) · 33.3% correct across 45 scored calls on equities See the full record